Furthermore, studies using cell counts of astrocytes – through Nissl staining (Pelvig et al., 2003) or constitutive astrocyte markers in combination with GFAP (Serrano-Pozo et al., 2013a) – showed no difference in cell number in AD compared to control brains. This evidence concerns the gene GFAP and Alzheimer disease.